🔎 Trials Near Me

Akèy › Kansè pankreyas › Kansas › Overland Park

Etid klinik pou Kansè pankreyas nan Overland Park, KS

7 etid pou Kansè pankreyas ap chèche patisipan nan sit nan ak bò kote Overland Park (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

Ap rekriteFaz 3
  • University of Kansas Cancer Center, Fairway · 3 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT07562152

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

Ap rekriteFaz 2/3
  • MidAmerica Cancer Care- American Oncology Partners, Merriam · 3 mi lwen
  • United Imaging Consultants, Lenexa · 4 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06989437

Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors

Ap rekriteFaz 1
  • University of Kansas, Fairway · 3 mi lwen
Laj 12 a 120 · Tout sèks · Mizajou Sep 23, 2026 · NCT04222413

Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer

Ap rekriteFaz 1/2
  • University of Kansas Cancer Center-Overland Park, Overland Park
  • University of Kansas Clinical Research Center, Fairway · 3 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT04172532

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

Ap rekriteFaz 3
  • University of Kansas Cancer Center-Overland Park, Overland Park
Laj 18 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT06958328

Integrated Cancer Repository for Cancer Research

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Saint Luke's Cancer Instititute - South, Overland Park
Laj 19 a 110 · Tout sèks · Mizajou Jun 29, 2026 · NCT02012699

A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

Ap rekriteFaz 1/2
  • The University of Kansas Cancer Center, Fairway · 3 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Mar 18, 2026 · NCT06244771

Etid Kansè pankreyas nan lòt vil

Lòt etid nan Overland Park

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.